Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Normanno N"'
Autor:
Nicla La Verde, Fiamma Buttitta, Maria Angela Bella, Massimo Barberis, Ettore Capoluongo, Chiara Trevisiol, Pierosandro Tagliaferri, Enrico Ricevuto, Nicola Normanno, Nicoletta Colombo, Matilde Pensabene, Antonio Russo, Sandro Pignata, Anna Sapino, Domenica Lorusso, Liliana Varesco, Maurizio Genuardi, Lorena Incorvaia, Massimo Gion, Valentina Guarneri, Laura Cortesi, Pierfrancesco Tassone, Paolo Radice, Mauro Truini, Paolo Marchetti, Stefania Gori, Antonio Marchetti, Barbara Pasini, Paola Carrera
The current availability of new Poly(ADP-ribose) Polymerase (PARP)-inhibitors for the treatment of ovarian cancer patients independently of the presence of a BRCA pathogenic variant, together with the validation of somatic test for the analysis of BR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942108ee20348ca4ec8b28d92ca4333a
http://hdl.handle.net/10447/437173
http://hdl.handle.net/10447/437173
Autor:
Giovanni Scambia, Cosimo Sacco, Giorgio Valabrega, Maria Carmela Piccirillo, Antonella Savarese, Pierosandro Tagliaferri, Rossella Lauria, Francesco Perrone, Ugo De Giorgi, Sabrina Chiara Cecere, Marilena Di Napoli, Saverio Cinieri, Gabriella Ferrandina, Ciro Gallo, Giulia Amadio, Maria Ornella Nicoletto, Vanda Salutari, Nicola Normanno, Sandro Pignata, Domenica Lorusso, Simona Losito, Giuseppa Maltese, Gennaro Daniele, Anna Maria Mosconi, Claudia Omarini, Alessandra Sacco, Carmela Pisano, Stefano Greggi, Simona Signoriello, Barbara Kopf, Francesco Raspagliesi
Publikováno v:
Gynecologic oncology. 153(3)
Background Cervical cancer cells often express Epidermal Growth Factor Receptor (EGFR). Cetuximab (CET), an anti-EGFR antibody, can be safely combined with carboplatin (C) and paclitaxel (P), a standard treatment for advanced/recurrent cervical cance
Autor:
Camerlingo R1, Miceli R2, Marra L1, Rea G3, D'Agnano I4, 5, Nardella M6, Montella R7, Morabito A8, Normanno N1, Tirino V7, Rocco G9
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219597 (2019)
PloS one (2019). doi:10.1371/journal.pone.0219597
info:cnr-pdr/source/autori:Camerlingo R1, Miceli R2, Marra L1, Rea G3, D'Agnano I4,5, Nardella M6, Montella R7, Morabito A8, Normanno N1, Tirino V7, Rocco G9/titolo:Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation/doi:10.1371%2Fjournal.pone.0219597/rivista:PloS one/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
PLoS ONE
PloS one (2019). doi:10.1371/journal.pone.0219597
info:cnr-pdr/source/autori:Camerlingo R1, Miceli R2, Marra L1, Rea G3, D'Agnano I4,5, Nardella M6, Montella R7, Morabito A8, Normanno N1, Tirino V7, Rocco G9/titolo:Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ß1 and miRNA21 cooperation/doi:10.1371%2Fjournal.pone.0219597/rivista:PloS one/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume
PLoS ONE
The epithelial-mesenchymal transition (EMT) plays a key role in tumor progression, drug resistance and metastasis. Recently, numerous microRNA (miRNA) have been described to regulate EMT in tumor progression. In this study, we found that conditioned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60cd40dddb39464ba4a15ce6d5e57891
http://hdl.handle.net/11591/423284
http://hdl.handle.net/11591/423284
Autor:
R. Labianca, Fortunato Ciardiello, J.-Y. Douillard, Alfredo Falcone, André D'Hoore, C.-H. Köhne, Aziz Zaanan, George Pentheroudakis, Dan Aderka, Nicola Normanno, Takayuki Yoshino, Per Pfeiffer, H.-J. Schmoll, Al B. Benson, J.H.J.M. van Krieken, René Adam, Demetris Papamichael, Paulo M. Hoff, Jens Ricke, R. Salazar, György Bodoky, Harpreet Wasan, Josep Tabernero, Timothy J. Price, Dirk Arnold, Michel Ducreux, Alberto Sobrero, Thomas Gruenberger, Brigette B.Y. Ma, Axel Grothey, E. Aranda Aguilar, E. Van Cutsem, Karin Haustermans, Volker Heinemann, Pia Österlund, Kei Muro, Arnaud Roth, Eduardo Díaz-Rubio, Pierre Laurent-Puig, Andrés Cervantes, Alberto Bardelli, Wim J.G. Oyen, Julien Taieb, C.J.A. Punt, Sabine Tejpar, Tim Maughan, Werner Scheithauer
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Annals of Oncology, 27, 1386-422
Van Cutsem, E, Cervantes, A, Adam, R, Sobrero, A, Van Krieken, J H, Aderka, D, Aranda Aguilar, E, Bardelli, A, Benson, A, Bodoky, G, Ciardiello, F, D'Hoore, A, Diaz-Rubio, E, Douillard, J-Y, Ducreux, M, Falcone, A, Grothey, A, Gruenberger, T, Haustermans, K, Heinemann, V, Hoff, P, Köhne, C-H, Labianca, R, Laurent-Puig, P, Ma, B, Maughan, T, Muro, K, Normanno, N, Österlund, P, Oyen, W J G, Papamichael, D, Pentheroudakis, G, Pfeiffer, P, Price, T J, Punt, C, Ricke, J, Roth, A, Salazar, R, Scheithauer, W, Schmoll, H J, Tabernero, J, Taïeb, J, Tejpar, S, Wasan, H, Yoshino, T, Zaanan, A & Arnold, D 2016, ' ESMO consensus guidelines for the management of patients with metastatic colorectal cancer ', Annals of Oncology, vol. 27, no. 8, pp. 1386-1422 . https://doi.org/10.1093/annonc/mdw235
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Annals of Oncology, 27, 8, pp. 1386-422
Annals of oncology, 27(8), 1386-1422. Oxford University Press
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Annals of Oncology, 27, 1386-422
Van Cutsem, E, Cervantes, A, Adam, R, Sobrero, A, Van Krieken, J H, Aderka, D, Aranda Aguilar, E, Bardelli, A, Benson, A, Bodoky, G, Ciardiello, F, D'Hoore, A, Diaz-Rubio, E, Douillard, J-Y, Ducreux, M, Falcone, A, Grothey, A, Gruenberger, T, Haustermans, K, Heinemann, V, Hoff, P, Köhne, C-H, Labianca, R, Laurent-Puig, P, Ma, B, Maughan, T, Muro, K, Normanno, N, Österlund, P, Oyen, W J G, Papamichael, D, Pentheroudakis, G, Pfeiffer, P, Price, T J, Punt, C, Ricke, J, Roth, A, Salazar, R, Scheithauer, W, Schmoll, H J, Tabernero, J, Taïeb, J, Tejpar, S, Wasan, H, Yoshino, T, Zaanan, A & Arnold, D 2016, ' ESMO consensus guidelines for the management of patients with metastatic colorectal cancer ', Annals of Oncology, vol. 27, no. 8, pp. 1386-1422 . https://doi.org/10.1093/annonc/mdw235
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP
Annals of Oncology, 27, 8, pp. 1386-422
Annals of oncology, 27(8), 1386-1422. Oxford University Press
Contains fulltext : 165965.pdf (Publisher’s version ) (Closed access) Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ccf2b801d4b95d9bd0bb5c50736ce1
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3106
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3106
Autor:
Nicola Normanno, Sylvie Ménard, Manuela Campiglio, A. De Luca, Monica R. Maiello, Luca Gianni, Giulia Somenzi, David S. Salomon, Fortunato Ciardiello
Publikováno v:
Annals of Oncology. 13:65-72
Background Co-expression of the epidermal growth factor receptor (EGFR) and of ErbB-2 is found in a subset of primary human breast cancer. Materials and methods The antiproliferative effects of anti-EGFR and anti-ErbB-2 agents were evaluated using a
Autor:
F Armenante, Ralf Brandt, Jing Lin, Brenda Jones, Fortunato Ciardiello, M G Persico, William J. Gullick, Nicola Normanno, D Schneider, R Harkins
Publikováno v:
Journal of Biological Chemistry. 269:17320-17328
The human and mouse cripto-1 (CR-1) genes can code for proteins related in structure to epidermal growth factor (EGF). A specific 36-kDa immunoreactive protein was detected by Western blot analysis in human cell lines that express CR-1 mRNA but not i
Autor:
Nicola Normanno, Gerardo Botti, Carmine Pinto, R Vincenzo Iaffaioli, Cristin Roma, Fabiana Tatangelo, Oscar Nappi, Anna Maria Rachiglio, Fortunato Ciardiello, Pietro Carotenuto
Aims: Patients with metastatic colorectal carcinoma (mCRC) carrying activating mutations of the KRAS gene do not benefit from treatment with anti-EGF receptor monoclonal antibodies. Therefore, KRAS mutation testing of mCRC patients is mandatory in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc6ee9ef57ca03156cfc1b16b63e9f8
http://hdl.handle.net/11591/199181
http://hdl.handle.net/11591/199181
Autor:
Domenico Ribatti, Nicola Normanno, Antonio Pinto, Antonella De Luca, Rosaria De Filippi, Marianna Gallo, Donatella Aldinucci, Amelia D'Alessio, Luana Lamura
Increasing evidence suggests that bone marrow-derived mesenchymal stem cells (MSCs) are recruited into the stroma of developing tumors where they contribute to cancer progression. MSCs produce different growth factors that sustain tumor-associated ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddbd7d7c3f73be6af0f9d8891987ea86
http://hdl.handle.net/11588/417550
http://hdl.handle.net/11588/417550
Autor:
Amelia D'Alessio, Anna Maria Rachiglio, Cristin Roma, Gerardo Botti, Pietro Carotenuto, Nicola Normanno
Publikováno v:
Scopus-Elsevier
Triple negative breast cancer is a subtype of breast cancer that lacks expression of an estrogen receptor (ER), a progesterone receptor (PR), and HER2. It is characterized by its unique molecular profile, aggressive behavior, and distinct pattern of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5cd2e06561dd9544bd1352efcbabf31
http://hdl.handle.net/11588/875884
http://hdl.handle.net/11588/875884
Autor:
S. Gail Eckhardt, Marco Romano, Gabriella Fontanini, Maria Pia Morelli, Giampaolo Tortora, Teresa Troiani, Roberto Bianco, Concetta Tuccillo, Tina Cascone, Nicola Normanno, Fortunato Ciardiello, Bianca Maria Veneziani, Sabino De Pacido
Purpose: The epidermal growth factor receptor (EGFR) autocrine pathway plays an important role in cancer cell growth. Vascular endothelial growth factor A (VEGF-A) is a key regulator of tumor-induced endothelial cell proliferation and vascular permea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01cc33e7d75508c471b899ed77f437ab
http://hdl.handle.net/11562/346881
http://hdl.handle.net/11562/346881